Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis

BACKGROUND: Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to explore the associations between enhancer of zeste homolog 2 (EZH2) and patient survival in various cancers. METHODS: Relevant literature was retrieved from PubMed and Web of Science database...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuling, Huang, Lixia, Sun, Kaiyu, Wu, Dexi, Li, Minrui, Li, Manying, Zhong, Bihui, Chen, Minhu, Zhang, Shenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431777/
https://www.ncbi.nlm.nih.gov/pubmed/25974088
http://dx.doi.org/10.1371/journal.pone.0125480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431777/
https://www.ncbi.nlm.nih.gov/pubmed/25974088
http://dx.doi.org/10.1371/journal.pone.0125480

Ejemplares similares